Research Management Group (RMG)

American Diabetes Association (ADA)
Pathway to Stop Diabetes
Visionary Award

**$1.625M Limited ADA “Visionary" Award funding opportunity for established senior investigators (faculty with PI eligibility) with exceptional productivity in fields other than diabetes research who would like to apply their expertise to innovative diabetes-related research topics. The program intends to attract a broad range of expertise to the field of diabetes from various fields of science and technology, including medicine, biology, chemistry, engineering, mathematics and physics.


The 2018 internal deadline has passed. This webpage is for your reference only.


This is one of three related limited ADA Pathway to Stop Diabetes Awards.
The other two programs are:

# of applicants: 1*

* Stanford is permitted ONE total nomination. It can be either an "Initiator" or an "Accelerator", or a "Visionary" applicant.



Internal deadline: Tuesday,  April 3, 2018, 5 p.m. (see the internal submission guidelines below)
For applicant selected:
Institutional representative (RPM/RMG) deadline: June 25, 2018
Sponsor deadline: July 2, 2018
Start date for funding: Jan. 1, 2019

Amount of funding:

Phase 1 provides up to three years of support at a maximum of $325,000 per year (including 30% indirect costs),
Phase 2* provides up to two years of support at a maximum of $325,000 per year (including 30% indirect costs).
*Phase 2 is contingent upon demonstration of significant contributions to the field of diabetes research in Phase 1. Combined support for Phase 1 and Phase 2 can total up to $1,625,000.


Download the application guidelines from this ADA webpage:
However, please see the eligibility and purpose sections and the internal submission guidelines on this webpage.


The Pathway Visionary Award is designed to support established, experienced investigators (faculty with PI eligibility) with strong records of outstanding productivity in fields outside of diabetes who are interested in applying their considerable skills and expertise to diabetes research. These awards are highly competitive and intended to support particularly innovative and transformational ideas that have the potential to have an exceptional impact in diabetes. In order to be competitive for this award, investigators should have:

Research Topics:
The Pathway to Stop Diabetes Research Program will consider applications directed toward all topics rele-vant to prevention, treatment and cure of all types of diabetes (type 1, type 2, and gestational diabetes), diabetes-related disease states (obesity, pre-diabetes, and other insulin resistant states) and the complica-tions of the disease. The program intends to attract a broad range of expertise to the field of diabetes from various fields of science and technology, including medicine, biology, chemistry, engineering, mathematics and physics.

Types of research: can be basic, clinical, or translational. For the purpose of this award, clinical research is defined as research directly involving humans, and includes educational, psychosocial, behavioral, epidemiologic, and health services research as well as clinical studies of normal physiology and mechanisms of disease. Translational research is defined as research that accelerates the transition of scientific discoveries into clinical applications, by efficiently advancing knowledge of efficacy to the next level of clinical application.

Review Criteria
Scientific excellence is the primary benchmark to be evaluated for all Pathway applications, with an emphasis on the investigator’s potential to significantly impact the field of diabetes research. The proposed research strategy serves as a reflection of the individual’s capacity for innovation, creativity and collaboration. The review will include the following components:

Principal Investigator:

Research Strategy:


Internal submission guidelines

By Tuesday, April 3, 2018, 5 p.m., please submit one PDF file containing the following in the order listed below to:

Jeanne Heschele
Research Management Group (RMG)

File name: Last name_ADA_Visionary.pdf

Faculty: You do not have to prepare a budget, or submit a PDRF form or proposals through your institutional representative (RPM or OSR)

1) Title Page
American Diabetes Association (ADA) Pathway to Stop Diabetes “Visionary Award"
Indicate Diabetes category relevant to the research: both Type 1 and Type 2 Diabetes; Type 1 Diabetes, Type 2 diabetes, Gestational Diabetes, obesity, pre-diabetes/insulin resistance
Research type: basic, clinical or translational
Project Title:
PI name, appointment, Department, address, phone, email

2) Nomination letter printed on your department or division's letterhead signed by your Division Chief or your Department Chair addressed to Dr. Peter Sarnow and the Awards Committee members.
Provide rationale for your nomination of candidate, including why candidate is uniquely suited for the award.
Certify that the candidate has the appropriate full-time position at the sponsoring institution as required by the award.
Outline the candidate’s responsibilities and ensure that at least 75% of the nominee’s total time and effort will be allocated to research during the term of this award.

3) "Research Strategy" Proposal- up to 4 page maximum
Formatting guidelines: Single-spaced, 1/2 inch margins, Font size 11 or larger, Ariel or Helvetica font. Figures can be included in the 4 page limit. References can be on a separate page and are not included in the four page limit

The research strategy should provide a high level description of your scientific question(s) and the strategy(ies) and approach(es) that you will employ to address this question. It should be written with a level of detail appropriate for reviewers who are knowledgeable of the field, but who may not be directly involved in the proposed area of research. The Research strategy section is flexible in format, does not require a detailed project plan or description of methods, or preliminary data. Figures are allowed, but must be included in the 4 page limit.

The research strategy should address the following components:
a) Scientific question(s)/specific problem(s) to be addressed
b) Specific approach(es) that will be employed
c) Significance and potential impact of the work
d) The potential risks and challenges, and how they will be overcome

4) NIH Biosketch

5) Other support (include current and pending support, sponsor, term, amount of funding)

Selection process

Your proposals will be reviewed by the School of Medicine Awards Committee. That committee will select the applicant to represent Stanford. (Note: there can only be one applicant- either an Accelerator, an Initiator, or a "Visionary" applicant)



Footer Links: